AngioDynamics (ANGO) Reports In-Line Q1 EPS of 8c; Reaffirms FY12 Outlook; Authorizes $20M Buyback
Tweet
Share
E-mailGet Alerts ANGO Hot Sheet
Price: $15.75 -0.44%
Financial Fact:
General and administrative: 8.17M
Today's EPS Names:
BTTX, VAXX, ELYS, More
Financial Fact:
General and administrative: 8.17M
Today's EPS Names:
BTTX, VAXX, ELYS, More
Join SI Premium – FREE
AngioDynamics, Inc. (NASDAQ: ANGO) reported Q1 EPS of $0.08, ex-items, which was in-line with the analyst estimate of $0.08. Revenue for the quarter came in at $54.4 million versus the consensus estimate of $53.86 million.
Reaffirms FY12 outlook.
AngioDynamics also reported today that the Company's Board of Directors has authorized the repurchase, prior to May 31, 2012, of up to $20 million of the Company's common stock.
Reaffirms FY12 outlook.
AngioDynamics also reported today that the Company's Board of Directors has authorized the repurchase, prior to May 31, 2012, of up to $20 million of the Company's common stock.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- BJ's Wholesale Club (BJ) Tops Q2 EPS by 19c, Beats on Revenue; Offers FY27 EPS Guidance
- TJX Cos. (TJX) Tops Q2 EPS by 3c, Beats on Revenue; Offers FY27 EPS Guidance
- Deere & Co. (DE) Tops Q3 EPS by 41c, raises guidance
Create E-mail Alert Related Categories
Earnings, Guidance, Stock BuybacksSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
